Viewing Study NCT02826434


Ignite Creation Date: 2025-12-25 @ 2:21 AM
Ignite Modification Date: 2026-01-08 @ 11:00 AM
Study NCT ID: NCT02826434
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-01
First Post: 2016-07-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer
Sponsor: Massachusetts General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module